Royal Bank of Canada’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $346M | Buy |
8,100,653
+1,827,390
| +29% | +$99.2M | 0.05% | 316 |
|
|
2026
Q1 | $394M | Buy |
6,273,263
+721,691
| +13% | +$57.7M | 0.07% | 257 |
|
|
2025
Q4 | $529M | Sell |
5,551,572
-2,161,017
| -28% | -$212M | 0.09% | 210 |
|
|
2025
Q3 | $753M | Buy |
7,712,589
+1,081,528
| +16% | +$112M | 0.12% | 154 |
|
|
2025
Q2 | $712M | Buy |
6,631,061
+1,618,799
| +32% | +$164M | 0.13% | 149 |
|
|
2025
Q1 | $506M | Sell |
5,012,262
-763,662
| -13% | -$76.9M | 0.11% | 179 |
|
|
2024
Q4 | $516M | Buy |
5,775,924
+938,023
| +19% | +$82.6M | 0.1% | 172 |
|
|
2024
Q3 | $405M | Buy |
4,837,901
+374,424
| +8% | +$29.5M | 0.08% | 221 |
|
|
2024
Q2 | $344M | Buy |
4,463,477
+166,366
| +4% | +$12.2M | 0.08% | 235 |
|
|
2024
Q1 | $294M | Sell |
4,297,111
-71,719
| -2% | -$4.61M | 0.07% | 262 |
|
|
2023
Q4 | $253M | Buy |
4,368,830
+696,891
| +19% | +$37.2M | 0.06% | 278 |
|
|
2023
Q3 | $194M | Buy |
3,671,939
+504,357
| +16% | +$26.5M | 0.05% | 300 |
|
|
2023
Q2 | $171M | Buy |
3,167,582
+596,549
| +23% | +$31.2M | 0.04% | 353 |
|
|
2023
Q1 | $129M | Sell |
2,571,033
-119,402
| -4% | -$5.63M | 0.04% | 402 |
|
|
2022
Q4 | $124M | Buy |
2,690,435
+178,629
| +7% | +$7.73M | 0.04% | 415 |
|
|
2022
Q3 | $97.3M | Buy |
2,511,806
+71,235
| +3% | +$2.86M | 0.03% | 444 |
|
|
2022
Q2 | $91M | Buy |
2,440,571
+133,684
| +6% | +$5.44M | 0.03% | 458 |
|
|
2022
Q1 | $102M | Buy |
2,306,887
+562,733
| +32% | +$24.4M | 0.03% | 489 |
|
|
2021
Q4 | $74.1M | Sell |
1,744,154
-659,363
| -27% | -$27.7M | 0.02% | 636 |
|
|
2021
Q3 | $104M | Sell |
2,403,517
-288,887
| -11% | -$12.8M | 0.03% | 473 |
|
|
2021
Q2 | $115M | Buy |
2,692,404
+749,112
| +39% | +$31.5M | 0.03% | 448 |
|
|
2021
Q1 | $75.1M | Sell |
1,943,292
-47,353
| -2% | -$1.79M | 0.02% | 545 |
|
|
2020
Q4 | $71.6M | Buy |
1,990,645
+363,450
| +22% | +$13.1M | 0.02% | 562 |
|
|
2020
Q3 | $62.2M | Sell |
1,627,195
-84,895
| -5% | -$3.27M | 0.02% | 537 |
|
|
2020
Q2 | $60.1M | Buy |
1,712,090
+386,961
| +29% | +$13.9M | 0.02% | 514 |
|
|
2020
Q1 | $43.2M | Sell |
1,325,129
-535,771
| -29% | -$20.9M | 0.02% | 547 |
|
|
2019
Q4 | $84.1M | Sell |
1,860,900
-795,401
| -30% | -$33.3M | 0.03% | 433 |
|
|
2019
Q3 | $108M | Sell |
2,656,301
-14,097
| -0.5% | -$597K | 0.04% | 355 |
|
|
2019
Q2 | $115M | Buy |
2,670,398
+279,690
| +12% | +$10.8M | 0.05% | 325 |
|
|
2019
Q1 | $91.8M | Buy |
2,390,708
+696,276
| +41% | +$26.6M | 0.04% | 363 |
|
|
2018
Q4 | $59.9M | Sell |
1,694,432
-84,261
| -5% | -$3.06M | 0.03% | 464 |
|
|
2018
Q3 | $68.9M | Buy |
1,778,693
+459,061
| +35% | +$16M | 0.03% | 471 |
|
|
2018
Q2 | $43.2M | Sell |
1,319,632
-246,381
| -16% | -$7.43M | 0.02% | 630 |
|
|
2018
Q1 | $42.8M | Buy |
1,566,013
+630,046
| +67% | +$17.1M | 0.02% | 653 |
|
|
2017
Q4 | $23.2M | Buy |
935,967
+211,445
| +29% | +$5.83M | 0.01% | 1039 |
|
|
2017
Q3 | $21.1M | Buy |
724,522
+40,793
| +6% | +$1.13M | 0.01% | 1046 |
|
|
2017
Q2 | $19M | Sell |
683,729
-99,473
| -13% | -$2.64M | 0.01% | 1090 |
|
|
2017
Q1 | $19.5M | Sell |
783,202
-775,846
| -50% | -$18.9M | 0.01% | 1048 |
|
|
2016
Q4 | $33.7M | Sell |
1,559,048
-407,036
| -21% | -$8.88M | 0.02% | 724 |
|
|
2016
Q3 | $46.8M | Sell |
1,966,084
-186,391
| -9% | -$4.45M | 0.03% | 535 |
|
|
2016
Q2 | $50.3M | Buy |
2,152,475
+548,356
| +34% | +$11.9M | 0.03% | 470 |
|
|
2016
Q1 | $30.2M | Sell |
1,604,119
-27,877
| -2% | -$490K | 0.02% | 681 |
|
|
2015
Q4 | $30.1M | Buy |
1,631,996
+875,992
| +116% | +$15.7M | 0.02% | 680 |
|
|
2015
Q3 | $12.4M | Sell |
756,004
-45,608
| -6% | -$780K | 0.01% | 1027 |
|
|
2015
Q2 | $14.2M | Sell |
801,612
-41,796
| -5% | -$747K | 0.01% | 1037 |
|
|
2015
Q1 | $15M | Sell |
843,408
-5,427
| -0.6% | -$85.8K | 0.01% | 991 |
|
|
2014
Q4 | $11.2M | Buy |
848,835
+354,270
| +72% | +$4.53M | 0.01% | 1150 |
|
|
2014
Q3 | $5.84M | Sell |
494,565
-202,361
| -29% | -$2.55M | ﹤0.01% | 1539 |
|
|
2014
Q2 | $8.9M | Buy |
696,926
+152,660
| +28% | +$1.99M | 0.01% | 1278 |
|
|
2014
Q1 | $7.36M | Sell |
544,266
-264,364
| -33% | -$3.47M | 0.01% | 1325 |
|
|
2013
Q4 | $9.72M | Buy |
808,630
+8,219
| +1% | +$97.1K | 0.01% | 1210 |
|
|
2013
Q3 | $9.4M | Sell |
800,411
-50,597
| -6% | -$547K | 0.01% | 1173 |
|
|
2013
Q2 | $7.89M | Buy |
+851,008
| New | +$7.22M | 0.01% | 1163 |
|
Other funds holding BSX
Royal Bank of Canada's BSX Position: Q2 2026 in Review
Royal Bank of Canada increased its Boston Scientific (BSX) stake by 29% in Q2 2026, buying an estimated $99.2M and bringing the position to 8,100,653 shares worth $346M. The position accounts for 0.05% of the portfolio, ranked #316.
Royal Bank of Canada first reported a position in BSX in Q2 2013 and has held it in 53 quarters since. The position peaked at $753M in Q3 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Royal Bank of Canada held 8,100,653 shares of Boston Scientific worth $346M as of Q2 2026.
- Royal Bank of Canada bought 1,827,390 Boston Scientific shares in Q2 2026, an estimated $99.2M.
- Boston Scientific made up 0.05% of Royal Bank of Canada's portfolio in Q2 2026, its #316 holding.
- Royal Bank of Canada first reported a position in Boston Scientific in Q2 2013 and has held it in 53 quarters since.
- Royal Bank of Canada's Boston Scientific position peaked at $753M in Q3 2025.
- 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.